Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19-2 | COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) | PFIZER\BIONTECH | 5 | GJ6796 | IM / LA |
Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084401:COVID-19 RESPIRATORY INFECTION; Narrative: 67 y/o male who presented to the ED on 8/17/24 w/ shortness of breath, malaise, and headache of one day's duration and was found to have COVID pneumonia. His ABG O2 on initial presentation was 58 and he was initially requiring O2 in order to maintain his oxygen saturations. He was admitted for management of his suspected COVID pneumonia. Patient discharged to home after completing treatment with remdesivir. Other Relevant HX: PMHx of T2DM w/ diabetic nephropathy, HTN, HLD, PTSD, GERD, OSA, and osteoarthritis of the knees s/p left TKA on 6/24/24 Other: Hospitalization for treatment of Covid infection s/p vaccination
Positive Covid-19 test Chest CT